NCBiotech Company Directory

A comprehensive listing of North Carolina's life science industry

Mapping large numbers of results may take a few moments.

Search Results

Showing 1 - 40 of 40 results found.

Activity Company Description Location
Company AskBio Activity: Research and Development Research and Development Company Description Asklepios BioPharmaceutical (AskBio) uses adeno-associated virus (AAV) technology to develop and manufacture gene therapies for rare diseases and other genetic disorders. Location Research Triangle Park
Company Atsena Therapeutics Inc. Activity: Research and Development Research and Development Company Description Atsena Therapeutics is developing ocular gene therapies to reverse or prevent blindness. Location Durham
Company Azenta Life Sciences RTP Activity: Contract Research and Testing Contract Research and Testing Company Description Azenta Life Sciences, formerly Genewiz, provides custom DNA sequencing, gene synthesis, genomics, next-generation sequencing and molecular biology in a GLP/cGMP regulatory environment. Location Research Triangle Park
Company Bedrock Therapeutics Inc. Activity: Research and Development Research and Development Company Description Bedrock Therapeutics is an AAV research and development company developing platform technologies and therapeutics. Location Raleigh
Company BioCytics Inc. Activity: Research and Development Research and Development Company Description BioCytics researches and develops personalized cellular immunotherapy cancer therapies with the latest technology and equipment. BioCytics also offers contract R&D and is co-located with its sister company, the Carolina BioOncology Institute. Location Huntersville
Company Black Swan Pharmaceuticals Inc. Activity: Research and Development Research and Development Company Description Black Swan Pharmaceuticals is developing preclinical gene targeting therapeutics for motor neurone disease (MND) / Amyotrophic Lateral Sclerosis (ALS) and other neurological disorders. Location Wake Forest
Company BridgeBio Gene Therapy Activity: Research and Development Research and Development Company Description BridgeBio Gene Therapy is developing a gene therapy for the treatment of a monogenic disease that presents in childhood. Location Raleigh
Company Cellective BioTherapy Inc. Activity: Research and Development Research and Development Company Description Cellective BioTherapy is developing cellular and monoclonal antibody-based platforms for treating cancers, autoimmunity and immunodeficiency through the manipulation of B cells and their functional subsets. Location Chapel Hill
Company CLAIRIgene LLC Activity: Research and Development Research and Development Company Description CLAIRIgene develops viral vector platforms for gene therapy products to treat central nervous system diseases and conditions. Location Durham
Company Couragen Biopharmaceutics LLC Activity: Research and Development Research and Development Company Description Couragen Biopharmaceutics develops gene and protein therapy products for preclinical and clinical use for the treatment of genetic and chronic diseases. Couragen also provides custom adeno-associated virus vectors as a tool for laboratory research. Location Chapel Hill
Company Creyon Bio Activity: Research and Development Research and Development Company Description Creyon Bio is a drug development company engineering RNA-based medicines and their components. Location Research Triangle Park
Company Denizen Biologics LLC Activity: Research and Development Research and Development Company Description Denizen Biologics develops gene therapy vectors to enhance the capability of genetic medicine and improve the outcomes for patients. Location Cary
Company Enzerna Biosciences Inc. Activity: Research and Development Research and Development Company Description Enzerna Biosciences is a pre-clinical stage company that is leveraging its proprietary RNA editing technology to develop long-term curative gene therapies for rare genetic disorders such as Huntington's Disease and Myotonic Dystrophy. Location Morrisville
Company Epigenos Biosciences Inc. Activity: Research and Development Research and Development Company Description Epigenos Biosciences develops personalized epigenome-based therapeutics that leverage site-specific DNA binding technologies to treat disease at the root of gene mis-regulation. Location Morrisville
Company FastBack Bio LLC Activity: Research and Development Research and Development Company Description FastBack Bio is developing CAR-T therapy for treatment of solid tumors. Location Raleigh
Company General Biosystems Inc. Activity: Contract Research and Testing Contract Research and Testing Company Description General Biosystems provides gene synthesis, molecular biology, and protein expression and purification services. Location Durham
Company GeneVentiv Therapeutics Inc. Activity: Research and Development Research and Development Company Description GeneVentiv Therapeutics is a gene therapy company developing treatments for blood diseases and disorders, including treatments for Hemophilia A and B with or without inhibitors and for Hemophilia Arthropathy, a degenerative joint disease. Location Raleigh
Company GENIE Therapeutics Activity: Research and Development Research and Development Company Description Genie Therapeutics develops a cosmetic gene therapy in a topical cream formulation to reduce wrinkles, regenerate collagen and restore aging skin. The delivery platform will be used to develop wound healing drugs. Location Winston-Salem
Company Immorna Biotherapeutics Inc. Activity: Research and Development Research and Development Company Description Immorna Biotherapeutics develops self-replicating and conventional mRNA-based therapeutics and vaccines. Location Raleigh
Company Imugene Limited (Durham) Activity: Research and Development Research and Development Company Description Imugene is a clinical stage immuno-oncology company developing treatments that seek to activate the immune system of cancer patients to identify and eradicate tumors. Location Durham
Company Inceptor Bio LLC Activity: Research and Development Research and Development Company Description Inceptor Bio develops next-generation cell therapy platforms, across multiple cell types, to cure cancers. Its site includes a manufacturing facility for production of its therapies. Location Raleigh
Company Isolere Bio Inc. Activity: Research and Development Research and Development Company Description Isolere Bio is developing novel, non-chromatographic technologies for the purification of biologics such as antibodies, gene delivery vectors and personalized cell therapies. Location Durham
Company Jaguar Gene Therapy LLC (Analytical Development) Activity: Research and Development Research and Development Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. The company's analytical development lab is located in Durham. Location Durham
Company Jaguar Gene Therapy LLC (Process Sciences Lab) Activity: Research and Development Research and Development Company Description Jaguar Gene Therapy develops gene therapies for patients suffering from severe genetic diseases. The company's process sciences lab is located in Cary. Location Cary
Company Life Edit Therapeutics Activity: Research and Development Research and Development Company Description Life Edit Therapeutics, an ElevateBio company, identifies novel genome editing systems from a database of microbial genomes. These systems are then developed for use as human therapeutics, both in-house and through external partnerships. Location Durham
Company Locus Biosciences Inc. Activity: Research and Development Research and Development Company Description Locus Biosciences is developing CRISPR-engineered bacteriophage (“crPhage”) products that kill target bacteria by irreversibly destroying their DNA while leaving the many species of beneficial bacteria in the body unharmed. Location Morrisville
Company NabGen Inc. Activity: Research and Development Research and Development Company Description NabGen has developed a universal antibody suppressant technology to inhibit anti-drug and autoimmune antibodies, including suppression of pre-existing immunity and re-administration barriers to gene therapies based on adeno-associated virus (AAV) vectors. Location Durham
Company NeuroGT Inc. Activity: Research and Development Research and Development Company Description NeuroGT is developing gene therapy products to treat rare neurogenetic diseases. Location Chapel Hill
Company Opus Genetics Inc. Activity: Research and Development Research and Development Company Description Opus Genetics is a clinical-stage gene therapy company developing treatments for inherited retinal diseases. Location Research Triangle Park
Company Pfizer Inc. (Durham) Activity: Research and Development Research and Development Company Description Pfizer develops gene therapies to treat rare genetic central nervous system (CNS) and neuromuscular diseases. Pfizer's BioTherapeutics Pharmaceutical Sciences site in Durham houses clinical manufacturing space and analytical research development laboratories. Location Durham
Company PhosphoGam Inc. Activity: Research and Development Research and Development Company Description PhosphoGam is developing allogeneic cell immunotherapies using gamma/delta T-cells to treat a variety of cancers. Location Durham
Company Precision BioSciences Inc. (Durham) Activity: Research and Development Research and Development Company Description Precision BioSciences is a clinical stage in vivo gene editing company using its novel ARCUS genome editing platform to develop new treatment options for genetic and infectious diseases. Location Durham
Company RainBio Inc. Activity: Research and Development Research and Development Company Description RainBio is developing AAV (adeno-associated virus) gene therapy corneal treatments to address the unmet need of treatment of rare corneal blinding diseases. Location Raleigh
Company Sarepta Therapeutics Inc. (Durham) Activity: Research and Development Research and Development Company Description Sarepta Therapeutics develops precision genetic medicine treatments for Duchenne muscular dystrophy (DMD), Limb-girdle muscular dystrophy (LGMD) and other central nervous system (CNS) disorders. Sarepta's Gene Editing Innovation Center is in Durham. Location Durham
Company SNP Therapeutics LLC Activity: Research and Development Research and Development Company Description SNP Therapeutics develops genetic tests to identify genetic variant patterns that contribute to disease. SNPT also designs nutritional therapeutics to treat metabolic disorders. Location Kannapolis
Company Sumitomo Pharma America Inc. (Cary) Activity: Research and Development Research and Development Company Description Sumitomo Pharma America develops regenerative therapeutics for rare diseases such as congenital athymia. Location Cary
Company TG Therapeutics Inc. Activity: Research and Development Research and Development Company Description TG Therapeutics is a commercial stage biopharmaceutical company focused on the acquisition, development and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Location Morrisville
Company Torque Bio Inc. Activity: Research and Development Research and Development Company Description Torque Bio is a start-up leveraging the power of technology to develop novel gene therapies. Location Durham
Company Tune Therapeutics Activity: Research and Development Research and Development Company Description Tune Therapeutics develops novel cell and gene therapy products with their epigenome editing and gene regulation platform, TEMPO. Location Durham
Company ViraSource LLC Activity: Contract Research and Testing Contract Research and Testing Company Description ViraSource propagates and purifies BSL-1, BSL-2 viruses and bacteriophages. ViraSource also provides virus modifications and animal models of viral infections and antiviral immune responses. Location Durham